- Report
- February 2026
- 250 Pages
Global
From €4067EUR$4,490USD£3,509GBP
- Report
- June 2026
- 388 Pages
Global
From €5299EUR$5,850USD£4,572GBP
- Report
- June 2026
- 377 Pages
Global
From €5299EUR$5,850USD£4,572GBP
- Report
- June 2026
- 270 Pages
Global
From €5299EUR$5,850USD£4,572GBP
- Report
- June 2026
- 284 Pages
Global
From €5299EUR$5,850USD£4,572GBP
- Report
- June 2026
- 184 Pages
Global
From €5299EUR$5,850USD£4,572GBP
- Report
- June 2026
- 311 Pages
Global
From €5299EUR$5,850USD£4,572GBP
- Report
- June 2026
- 189 Pages
Global
From €5299EUR$5,850USD£4,572GBP
- Report
- June 2026
- 177 Pages
Global
From €5299EUR$5,850USD£4,572GBP
- Report
- June 2026
- 400 Pages
Global
From €5299EUR$5,850USD£4,572GBP
- Report
- June 2026
- 188 Pages
Global
From €5299EUR$5,850USD£4,572GBP
- Report
- June 2026
- 479 Pages
Global
From €5299EUR$5,850USD£4,572GBP
- Report
- June 2026
- 193 Pages
Global
From €5299EUR$5,850USD£4,572GBP
- Report
- April 2026
- 132 Pages
Global
From €4302EUR$4,750USD£3,712GBP
- Report
- March 2026
- 150 Pages
Global
From €3397EUR$3,750USD£2,931GBP
- Report
- November 2025
- 150 Pages
Global
From €3397EUR$3,750USD£2,931GBP
- Report
- November 2025
- 150 Pages
Global
From €3397EUR$3,750USD£2,931GBP
- Report
- July 2025
- 350 Pages
Global
From €4483EUR$4,949USD£3,868GBP
- Report
- November 2025
- 143 Pages
Global
From €3578EUR$3,950USD£3,087GBP
- Report
- February 2026
- 200 Pages
Global
From €4524EUR$4,995USD£3,903GBP

The Ventricular Assist Device (VAD) market is a subset of the Cardiovascular Devices market. VADs are mechanical pumps that are implanted in the body to help the heart pump blood. They are used to treat heart failure, bridge patients to heart transplantation, and provide long-term support for patients with end-stage heart failure. VADs are typically used in patients who are not eligible for heart transplantation or who are waiting for a donor heart.
VADs are classified into two main categories: left ventricular assist devices (LVADs) and right ventricular assist devices (RVADs). LVADs are used to support the left ventricle, while RVADs are used to support the right ventricle. Both types of VADs are designed to improve the quality of life of patients with heart failure.
Some companies in the VAD market include Abiomed, Medtronic, Thoratec, and SynCardia. Show Less Read more